CAROLINE NABEA: Open Payments
NPI 1831588847 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 27 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $543 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $175 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Astellas Pharma US Inc | 3 | $60 |
| PFIZER INC. | 2 | $36 |
| Abbott Laboratories | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Teleflex LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
Products named: BREZTRI, TRELEGY ELLIPTA, Veozah, AIRSUPRA, REXULTI, ELIQUIS, FREESTYLE LIBRE 3, GEMTESA.
Industry payments across AZ — which companies pay providers there.
